Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals' planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making…
News February 5Jazz Pharmaceuticals' planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making…
News February 5The market for buying and selling licensed cannabis businesses has perhaps never been hotter, with demand fueled by…
News February 5Cannabis multistate operator iAnthus said it has closed on $11 million of financing to complete a build-out and…
News February 4A Democratic election trifecta - control of the White House and both chambers of Congress - is giving…
News February 4Global pharma company Jazz Pharmaceuticals has reached an agreement to buy U.K.-based GW Pharmaceuticals, one of the largest…
News February 3The owners of the Kool menthol cigarette brand filed a lawsuit that claims a California cannabis business has…
News February 2While U.S. cannabis markets might appear similar on the surface, each is driven by different consumer spending habits…
News February 2The cannabis vapor pen market sector has lost market share and not grown as fast as the rest…
News February 1It’s the Wild West out there!” How often have you heard that statement made about health claims for…
News February 1Partnership disputes—whether between business partners or owners and investors—continue to be an ugly feature of the cannabis industry.…
News February 1